Unknown NA INTERVENTIONAL 3-arm NCT02768909

Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB

Sponsor: Foundation for Research in Mycobacteria (FUNDAIM)

Conditions Tuberculosis, Pulmonary e-Nose

Interventions Chest X-ray E-Nose Follow Up 15 days after beginning of Tx. Follow Up 30 days after beginning of Tx. Follow Up 5 days after beginning of Tx. Follow Up 60 days after beginning of Tx. Sputum Samples Survey & Physical Exam

Updated 6 times since 2017 Last updated: May 9, 2016 Started: Jan 31, 2015 Primary completion: Dec 31, 2016 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02768909, this NA trial focuses on Tuberculosis, Pulmonary and e-Nose and remains ongoing. Sponsored by Foundation for Research in Mycobacteria (FUNDAIM), it has been updated 6 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Feb 2019 — Jan 2021 [monthly]

Unknown Status NA
Jun 2018 — Feb 2019 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Foundation for Research in Mycobacteria (FUNDAIM)
The ENose Company, Zutphen, Netherlands
Universidad Central de Venezuela

Data source: Universidad Central de Venezuela

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Caracas, Venezuela